VidIQ Logo
加藤幸成の抗体創薬チャンネル Image Thumbnail
加藤幸成の抗体創薬チャンネル

@kato-y188 videos14 yrs

加藤幸成の抗体創薬チャンネル's Latest YouTube Videos & Shorts

Subs1.03M

172Kin 28d

Views4.65M

787.09Kin 28d

Est. revenue$2.8K

Down 11%vs prior 14d

Last updated

OverviewVideosAbout

As of 2026-10-31, 加藤幸成の抗体創薬チャンネル has 1,030,000 subscribers, 4,648,757 total views, and 188 videos. Ranked #71,626 worldwide, #1,010 in Japan and #2,531 in Education by subscribers.

加藤幸成の抗体創薬チャンネル’s most recent 48 uploads

  • The latest upload vidIQ has for 加藤幸成の抗体創薬チャンネル is “第４５回 抗体創薬学分野 研究成果紹介：CDH16に対する抗体作製”, a long-form video published Oct 23, 2026.
  • These are 加藤幸成の抗体創薬チャンネル’s 48 most recent public uploads vidIQ has data for, published between Jul 3, 2026 and Oct 23, 2026 (48 long-form videos).
  • Median views across these 48 uploads: 713. 24 videos are above that median and 24 below.
  • Most viewed in the sample: “薬理学総論４−３（2026年薬理学講義・まとめ編）：アゴニスト・アンタゴニスト” (3,452 views, Sep 16, 2026). Least viewed: “神経薬理学５（2026年薬理学講義・まとめ編）” (65 views, Jul 16, 2026).
  • Median length: 15:36 for 48 long-form videos.
  • In this sample, 加藤幸成の抗体創薬チャンネル’s consecutive uploads were a median of 0 days apart (shortest gap 0 days, longest 14 days).
  • Views are lifetime totals as of Oct 31, 2026, so newer uploads have had less time to collect them. These figures describe only the videos listed here, not the whole channel, and do not show why any video performed as it did. Dates are UTC.
加藤幸成の抗体創薬チャンネル’s most recent uploads, newest first, with publication date (UTC), format, lifetime views and length
VideoPublished (UTC)ViewsLength
第４５回 抗体創薬学分野 研究成果紹介：CDH16に対する抗体作製1,93510:37
抗体創薬学−２（2026年薬理学講義・まとめ編）：抗体の基本2,8715:31
第４４回 抗体創薬学分野 研究成果紹介：EphA1に対する抗体作製2,18910:05
抗体創薬学−１（2026年薬理学講義・まとめ編）：分子標的薬総論3,2038:27
第４３回 抗体創薬学分野 研究成果紹介：CDH13に対する抗体作製2,10212:01
薬理学総論４−３（2026年薬理学講義・まとめ編）：アゴニスト・アンタゴニスト3,45220:27
薬理学総論４−２（2026年薬理学講義・まとめ編）：解離定数2,8626:36
薬理学総論４−１（2026年薬理学講義・まとめ編）：TGFβ・JAK-STAT2,3674:33
薬理学総論１−３（2026年薬理学講義・まとめ編）：バイオシミラーとジェネリック1,9916:44
薬理学総論１−２（2026年薬理学講義・まとめ編）：薬の名前の付け方1,4015:59
神経薬理学６−１−２（2026年薬理学講義・まとめ編）：パーキンソン病（最近の話題）1,26512:13
薬理学総論１−１（2026年薬理学講義・まとめ編）：薬理学の分類1,8342:40
神経薬理学６−１−１（2026年薬理学講義・まとめ編）：パーキンソン病1,70918:45
神経薬理学６−１（2026年薬理学講義・まとめ編）：パーキンソン病（長編）1,21931:06
神経薬理学５−３（2026年薬理学講義・まとめ編）：ADHD・ナルコレプシー1,8106:54
神経薬理学５−２（2026年薬理学講義・まとめ編）：双極性障害9283:25
神経薬理学５−１（2026年薬理学講義・まとめ編）：うつ病9909:32
神経薬理学４（2026年薬理学講義・まとめ編）：統合失調症79223:12
循環器薬理５−２（2026年薬理学講義・まとめ編）：狭心症72923:54
循環器薬理５−１（2026年薬理学講義・まとめ編）：心不全63615:32

vidIQ MCP

Audit 加藤幸成の抗体創薬チャンネル in ChatGPT or Claude

Add vidIQ to your AI assistant and ask “Audit 加藤幸成の抗体創薬チャンネル’s last 48 videos and tell me which ones got more views than the median of those videos.” It answers with live vidIQ data. Included in every plan, even Free.

This page covers public data only. A channel owner can connect their own YouTube channel to vidIQ to add private analytics, such as retention and traffic sources, to the audit.

Add to ChatGPTAdd to Claude

Counts reflect public YouTube data and may be rounded. Earnings are modelled ad revenue estimates, not reported creator income; sponsorships, memberships and merchandise are excluded.

The exact earnings measurement window is unavailable.

Data sources and methodology
Cite these statistics

vidIQ. As of 2026-10-31, 加藤幸成の抗体創薬チャンネル has 1,030,000 subscribers, 4,648,757 total views, and 188 videos. It ranks #71,626 by subscribers among channels tracked by vidIQ. Source: public YouTube statistics recorded by vidIQ. https://vidiq.com/youtube-stats/channel/@kato-y/ Methodology: https://vidiq.com/youtube-stats/top/methodology/

YouTube sourceShareable history chartResearch and media guide

See stats like these on every channel

Subscribers, views, earnings, and rankings